Mohamad Cherry
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 25
- Acute Myeloid Leukemia Research 18
- Chronic Myeloid Leukemia Treatments 9
- Hematopoietic Stem Cell Transplantation 4
- Oncology 17
- CAR-T cell therapy research 9
- Co-authors
- Sami Ibrahimi (4 shared papers)Manish R. Patel (5 shared papers)Jesús G. Berdeja (3 shared papers)Ian W. Flinn (3 shared papers)Mark J. Levis (6 shared papers)Alexander E. Perl (6 shared papers)Joseph G. Jurcic (6 shared papers)Gary J. Schiller (7 shared papers)
- Journals
- Blood (25 papers)Journal of Clinical Oncology (5 papers)Transfusion (1 paper)Hematology/Oncology Clinics of North America (1 paper)HemaSphere (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Mohamad Cherry
51 papers receiving 396 citations
Peers
Comparison fields: 5 of 44
- Hematology 177
- Genetics 132
- Pathology and Forensic Medicine 91
- Internal Medicine 16
- Oncology 112
Countries citing papers authored by Mohamad Cherry
This map shows the geographic impact of Mohamad Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamad Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamad Cherry more than expected).
Fields of papers citing papers by Mohamad Cherry
This network shows the impact of papers produced by Mohamad Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamad Cherry. The network helps show where Mohamad Cherry may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohamad Cherry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 53 | |
| 2 | 2019 | 33 | |
| 3 | 2017 | 30 | |
| 4 | 2023 | 29 | |
| 5 | 2020 | 25 | |
| 6 | 2017 | 23 | |
| 7 | 2017 | 19 | |
| 8 | 2017 | 14 | |
| 9 | 2015 | 14 | |
| 10 | 2024 | 12 | |
| 11 | 2020 | 12 | |
| 12 | 2020 | 11 | |
| 13 | 2014 | 9 | |
| 14 | 2021 | 8 | |
| 15 | 2017 | 8 | |
| 16 | 2014 | 8 | |
| 17 | 2012 | 7 | |
| 18 | Efficacy of BACTEC TB in the rapid confirmatory diagnosis of mycobacterial infections. A Lebanese tertiary care center experience. | 2006 | 6 |
| 19 | 2017 | 6 | |
| 20 | 2022 | 5 |
About Mohamad Cherry
Mohamad Cherry is a scholar working on Hematology, Oncology, Genetics, Immunology and Pathology and Forensic Medicine, having authored 55 papers that have together received 401 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (18 papers), Chronic Lymphocytic Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (9 papers), CAR-T cell therapy research (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Biosimilars and Bioanalytical Methods (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Hematology (177 citations), Genetics (132 citations), Pathology and Forensic Medicine (91 citations), Internal Medicine (16 citations) and Oncology (112 citations). Mohamad Cherry has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Sami Ibrahimi, Manish R. Patel, Jesús G. Berdeja, Ian W. Flinn, Mark J. Levis, Alexander E. Perl, Joseph G. Jurcic, Gary J. Schiller, José C. Cruz and Keith W. Pratz. Their work appears in journals such as Blood, Journal of Clinical Oncology, Transfusion, Hematology/Oncology Clinics of North America and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.